{
    "2021-05-06": [
        [
            {
                "time": "",
                "original_text": "曾助力新药上市缩短8个月，为创新持续加速，这家公司凭什么？",
                "features": {
                    "keywords": [
                        "新药",
                        "上市",
                        "创新",
                        "加速"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "生物医药行业动态跟踪报告：医药行业业绩增速逐季上行 子行业持续分化",
                "features": {
                    "keywords": [
                        "生物医药",
                        "业绩增速",
                        "逐季上行",
                        "子行业分化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "深度*行业*医药生物行业2020年年报与2021年一季报综述：疫情对行业产生持续影响、21年中小市值策略占优",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报",
                        "疫情",
                        "持续影响",
                        "中小市值策略"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年年报及2021年一季报总结：Q1业绩复苏回暖 看好CXO、疫苗、创新器械和服务等高景气板块",
                "features": {
                    "keywords": [
                        "医药",
                        "年报",
                        "Q1业绩复苏",
                        "CXO",
                        "疫苗",
                        "创新器械",
                        "服务",
                        "高景气板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}